Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
暂无分享,去创建一个
[1] N. Watts. Treatment of osteoporosis with bisphosphonates. , 2001, Rheumatic diseases clinics of North America.
[2] J. Burgess,et al. Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1 , 1998, Cancer.
[3] Burgess,et al. Expression of the MEN‐1 gene in a large kindred with multiple endocrine neoplasia type 1 , 1998, Journal of internal medicine.
[4] P. Ross. Risk factors for osteoporotic fracture. , 1998, Endocrinology and metabolism clinics of North America.
[5] I. Reid. The roles of calcium and vitamin D in the prevention of osteoporosis. , 1998, Endocrinology and metabolism clinics of North America.
[6] R. Lindsay. The role of estrogen in the prevention of osteoporosis. , 1998, Endocrinology and metabolism clinics of North America.
[7] S. Silverberg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Treatment of Hypercalcemia Secondary to Parathyroid Carcinoma with a Novel Calcimimetic Agent , 1997 .
[8] J. Burgess,et al. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. , 1998, Archives of surgery.
[9] E. Thurfjell,et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. , 1997, Surgery.
[10] S. Silverberg,et al. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. , 1996, The Journal of clinical endocrinology and metabolism.
[11] N. Thompson. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient , 1995, Journal of internal medicine.
[12] E. Siris,et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. , 1995, The Journal of clinical endocrinology and metabolism.
[13] J. Rastad,et al. Multiple endocrine neoplasia type 1. Clinical features and screening. , 1994, Endocrinology and metabolism clinics of North America.
[14] L. Mallette. Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. , 1994, Endocrinology and metabolism clinics of North America.
[15] E. Romagnoli,et al. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. , 1993, Bone and mineral.
[16] J. Valvanne,et al. Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years , 1992, Journal of internal medicine.
[17] J. Shepherd. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? , 1991, Archives of surgery.
[18] J. Nordenström,et al. Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. , 1990, Surgery.
[19] T. Clemens,et al. Skeletal disease in primary hyperparathyroidism , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] M. Brandi,et al. Familial multiple endocrine neoplasia type I: a new look at pathophysiology. , 1987, Endocrine reviews.
[21] R M Neer,et al. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25‐dihydroxyvitamin D , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.